(R)-N-(4-(4-chlorophenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide

ID: ALA2071001

PubChem CID: 53488283

Max Phase: Preclinical

Molecular Formula: C22H22ClN3O3S2

Molecular Weight: 476.02

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N2CCCC[C@@H]2C(=O)Nc2nc(-c3ccc(Cl)cc3)cs2)cc1

Standard InChI:  InChI=1S/C22H22ClN3O3S2/c1-15-5-11-18(12-6-15)31(28,29)26-13-3-2-4-20(26)21(27)25-22-24-19(14-30-22)16-7-9-17(23)10-8-16/h5-12,14,20H,2-4,13H2,1H3,(H,24,25,27)/t20-/m1/s1

Standard InChI Key:  UEILPNWTGNXVFQ-HXUWFJFHSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   16.5458  -22.5667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1375  -23.2833    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.9623  -23.2786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0000  -22.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0000  -22.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7120  -23.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4240  -22.8708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4240  -22.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7120  -21.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1367  -24.1094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4206  -24.5191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4191  -25.3434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1335  -25.7577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8509  -25.3418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8489  -24.5190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1397  -21.6354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8530  -22.0500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1421  -20.8104    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8578  -20.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6379  -20.6699    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1356  -20.0119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6636  -19.3352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8743  -19.5751    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   18.9580  -20.0307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3560  -20.7546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1800  -20.7708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6071  -20.0639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2041  -19.3392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3813  -19.3265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1334  -26.5827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4320  -20.0787    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 15 10  1  0
  6  7  1  0
  8 16  1  6
  7  8  1  0
 16 17  2  0
  8  9  1  0
 16 18  1  0
  7  2  1  0
 18 19  1  0
 19 20  2  0
  3  2  2  0
  2 10  1  0
  4  5  1  0
 10 11  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 19  1  0
 11 12  1  0
 24 25  2  0
  2  1  2  0
 25 26  1  0
 12 13  2  0
 26 27  2  0
  4  9  1  0
 27 28  1  0
 13 14  1  0
 28 29  2  0
 29 24  1  0
 21 24  1  0
  5  6  1  0
 13 30  1  0
 14 15  2  0
 27 31  1  0
M  END

Associated Targets(Human)

KCNQ1 Tclin Voltage-gated potassium channel subunit Kv7.1 (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 476.02Molecular Weight (Monoisotopic): 475.0791AlogP: 4.95#Rotatable Bonds: 5
Polar Surface Area: 79.37Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.75CX Basic pKa: CX LogP: 5.49CX LogD: 5.34
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.57Np Likeness Score: -2.30

References

1. Mattmann ME, Yu H, Lin Z, Xu K, Huang X, Long S, Wu M, McManus OB, Engers DW, Le UM, Li M, Lindsley CW, Hopkins CR..  (2012)  Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator.,  22  (18): [PMID:22910039] [10.1016/j.bmcl.2012.07.060]

Source